Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 3
1991 2
1993 1
1995 1
1996 1
1997 1
1999 1
2004 2
2005 1
2006 2
2007 2
2008 1
2009 2
2010 1
2011 1
2012 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for campa t[au]
Your search for Champa T[au] retrieved no results
Palliative sedation at the end of life at a tertiary cancer center.
Caraceni A, Zecca E, Martini C, Gorni G, Campa T, Brunelli C, De Conno F. Caraceni A, et al. Among authors: campa t. Support Care Cancer. 2012 Jun;20(6):1299-307. doi: 10.1007/s00520-011-1217-6. Epub 2011 Jul 16. Support Care Cancer. 2012. PMID: 21766162
Tolerability of the synthetic retinoid Fenretinide (HPR).
Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M, Andreoli C, Del Vecchio M, et al. Costa A, et al. Among authors: campa t. Eur J Cancer Clin Oncol. 1989 May;25(5):805-8. doi: 10.1016/0277-5379(89)90124-7. Eur J Cancer Clin Oncol. 1989. PMID: 2525470 Clinical Trial.
Long-term tolerability of fenretinide (4-HPR) in breast cancer patients.
Rotmensz N, De Palo G, Formelli F, Costa A, Marubini E, Campa T, Crippa A, Danesini GM, Delle Grottaglie M, Di Mauro MG, et al. Rotmensz N, et al. Among authors: campa t. Eur J Cancer. 1991;27(9):1127-31. doi: 10.1016/0277-5379(91)90309-2. Eur J Cancer. 1991. PMID: 1835622 Clinical Trial.
Normal-release oral morphine starting dose in cancer patients with pain.
Ripamonti CI, Campa T, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, De Conno F; MERITO Study Group. Ripamonti CI, et al. Among authors: campa t. Clin J Pain. 2009 Jun;25(5):386-90. doi: 10.1097/AJP.0b013e3181929b4f. Clin J Pain. 2009. PMID: 19454871 Clinical Trial.
Chest X-ray survey in the follow-up of breast cancer patients.
Ciatto S, Pacini P, Andreoli C, Cecchini S, Iossa A, Grazzini G, Buranelli F, Campa T, Costa A, Magni A, et al. Ciatto S, et al. Among authors: campa t. Br J Cancer. 1989 Jul;60(1):102-3. doi: 10.1038/bjc.1989.229. Br J Cancer. 1989. PMID: 2803907 Free PMC article.
Can fenretinide protect women against ovarian cancer?
De Palo G, Veronesi U, Camerini T, Formelli F, Mascotti G, Boni C, Fosser V, Del Vecchio M, Campa T, Costa A, et al. De Palo G, et al. Among authors: campa t. J Natl Cancer Inst. 1995 Jan 18;87(2):146-7. doi: 10.1093/jnci/87.2.146. J Natl Cancer Inst. 1995. PMID: 7707390 Clinical Trial. No abstract available.
23 results